CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The Psorax35 project aims to develop an oral treatment for mild to moderate psoriasis, addressing the need for safer and more effective options. This medicine could also positively impact related health issues, improving patients' quality of life and reducing healthcare costs.
The objective of the main project is to commercialize Psorax35 – the first oral medicine for mild to moderate psoriasis with positive effect on comorbidities.
Current psoriasis medicines have limited efficacy, serious side effects and waning effect over time.
According to WHO there is a global need for new safe, tolerable, effective and convenient psoriasis medicines that can be given without close monitoring by health personnel.
Developing and documenting Psorax35 as an efficacious treatment of…
ARCTIC NUTRITION AS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
